https://www.selleckchem.com/pr....oducts/ro-61-8048.ht
IPRO showed similar prognostic power (concordance index [C-index] 1-year 0.72, 2-year 0.70, 5-year 0.68) compared with that of TNM staging (C-index 1-year 0.71, 2-year 0.71, 5-year 0.7 in predicting 1-year, 2-year, and 5-year mortality. The Ensemble risk score yielded superior performance across all time points (C-index 1-year 0.77, 2-year 0.77, 5-year 0.76). IPRO stratified patients within TNM stages, discriminating between highest- and lowest-risk quintiles in stages I (HR 8.6, II (HR 5.03), III (HR 3.18), and IV (HR 1.91). Dee
Like
Comment
Share
